Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure
Saved in:
Main Authors: | Anna Lukačišinová (Author), Helena Skácelová (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of children's entry to labor market on health expenditures of urban household
by: Mahdi Shahraki, et al.
Published: (2019) -
The Last Entry
by: Russell, William Clark, 1844-1911 -
Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe
by: Jacoline C. Bouvy, et al.
Published: (2018) -
Internationalization of Traditional/Complementary Medicine products: market entry as medicine
by: Jiatong Li, et al.
Published: (2018) -
The Effects of Market Structure and Payment Rate on the Entry of Private Health Plans into the Medicare Market
by: Austin B. Frakt, et al.
Published: (2012)